Log in to save to my catalogue
Log in to save to my catalogue

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

| Ask | Become a Library member

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_878819719

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

About this item

Publication information

Publisher

United States: Massachusetts Medical Society

Subjects

Subjects and topics

More information

Scope and Contents

Contents

BEACOPP combination chemotherapy was compared with ABVD chemotherapy in advanced Hodgkin's disease. BEACOPP therapy was associated with higher initial rates of complete response and freedom from relapse but also with more short-term and long-term toxic effects.
The regimen of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) was introd...

Alternative Titles

Full title

ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_878819719

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_878819719

Other Identifiers

ISSN

0028-4793

E-ISSN

1533-4406

DOI

10.1056/NEJMoa1100340

How to access this item

Log in as a Library member

Full text available

About resource

View in old catalogue

Connecting people and collections